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Abstract
Genome-Wide Association Studies are typically
conducted using linear models to find genetic vari-
ants associated with common diseases. In these
studies, association testing is done on a variant-by-
variant basis, possibly missing out on non-linear
interaction effects between variants. Deep net-
works can be used to model these interactions, but
they are difficult to train and interpret on large
genetic datasets. We propose a method that uses
the gradient based deep interpretability technique
named DeepLIFT to show that known diabetes
genetic risk factors can be identified using deep
models along with possibly novel associations.
1. Introduction
A Genome-Wide Association Study (GWAS) (Bush &
Moore, 2012) aims at identifying common genetic vari-
ants associated with a trait of interest. Various diseases,
e.g. diabetes, and continuous measurements, e.g. LDL-
cholesterol, have been studied using GWAS. They are typ-
ically conducted using Single-Nucleotide Polymorphisms
(SNPs) scattered across the genome, which are genetic vari-
ants consisting of a single base-pair change in DNA. The
SNPs are tested one-by-one using multifield linear models
relating them to the target outcome, and statistical hypothe-
sis testing is used to find variants with non-null effects.
Even though GWAS associations can’t directly be inter-
preted as causal, they can help predict risk of complex dis-
eases, identify possible drug targets or gain insight into dis-
ease biology by highlighting relevant genetic loci. Despite
their many successes, GWAS are limited to the identification
of genetic variants with strong marginal effects, possibly
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leaving out a large number of genetic effects governed by
SNP-SNP interactions or other non-linear effects. These ef-
fects may play an important role in complex diseases (Bell
et al., 2011). Since deep networks are known to be able to
model arbitrarily complicated non-linear functions of their
inputs (Goodfellow et al., 2016), we aim to use them to
predict complex disease outcomes from genetic data, and
then interpret them (sample by sample) to discover novel
interactions between SNPs that are significant predictors of
the disease outcome.
Previous works (Tran & Blei, 2018; Wang & Blei, 2019)
have formulated GWAS as a problem of causal inference
with multiple causes of (typically) a single trait and with
hidden confounding. They use deep networks to model
complex traits on both simulated as well as real datasets
with up to approximately 300,000 SNPs and 5,000 individ-
uals. They proceed to conduct a likelihood ratio test on
the fitted deep models to identify strongly associated SNPs.
Likelihood ratio testing for each SNP can be resource and
time consuming, when considering hundreds of thousands
of SNPs, as it requires training two distinct models per SNP.
In this work, we use DeepLIFT (Shrikumar et al., 2017),
a reference-based feature attribution technique, to identify
the SNPs used by a feedforward model trained to identify
individuals with a given trait. This allows us to train and
interpret a single deep model to yield a list of potentially
causal SNPs. We use the implementation found in Pytorch-
Captum (Paszke et al., 2019) to interpret the trained models.
Movva et al. (2019) use DeepLift on a Convolutional Neural
Network (CNN) to identify SNPs that could potentially reg-
ulate gene activity. They use the predictions of their model
to supplement GWAS results and isolate causal variants.
In contrast, we are using DeepLIFT to find putative causal
variants by directly predicting traits of interest.
We first summarize the proposed methods for conducting
a GWAS using a deep learning pipeline (Sec. 2). We then
consider simulated (Sec. 3.1) as well as real (Sec. 3.2) data
to conduct a set of experiments where we show that we
are able to identify the SNPs for predicting discrete and
continuous traits (Sec. 4). 1
1The code to reproduce the simulation results can be found here
or (shorturl.at/oT056). This research has been conducted using the
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Contributions We believe that this work is the first
demonstration of the applicability of recent progress in in-
terpretability of deep models to GWAS. We have shown that
there is a considerable overlap between DeepLIFT identified
variants and known GWAS signals. We provide a working
pipeline with both simulated and real data. This lays the
ground to the next step, which is to further characterize as-
sociations identified by DeepLIFT and not by conventional
GWAS and to relate them to SNP-SNP interaction effects.
2. Methods
Consider a dataset D of N individuals with M SNPs.
Step 1: Train a feedforward model Using a training
set DT ⊂ D, we train a feedforward model to output a
prediction tˆn given input SNPs zn. One can use the typical
Mean Squared Error or Cross Entropy as a loss for that task.
Step 2: Apply DeepLIFT Using a validation set DV ⊂
D such that DV ∩ DT = ∅, we use DeepLIFT (Shrikumar
et al., 2017) to identify the saliency of input points according
to how sensitive the output of the network is to the presence
of a certain input feature compared to its baseline (or ref-
erence value). This reference value is picked appropriately
for the question at hand. In GWAS, the question is whether
mutations of SNPs from their expected values plays a role in
a disease. Therefore, we pick the mean allele frequency for
each SNP as our reference value. This allows to visualize
the saliency of SNPs in the dataset against their average.
More precisely, let x denote the input neurons for our model
and let t be the target output neuron. Let xref and tref be the
input and target neuron outputs when the model receives the
reference input. Let ∆x = x − xref and ∆t = t − tref be
the difference in the outputs of the input and target neurons
from their respective reference outputs.
DeepLIFT assigns a score for each input neuron xi s.t.
∆t =
L∑
i=1
C∆xi∆t, (1)
where L is the number of input neurons and C∆xi∆t can
be thought of as a weight assigned to each input neuron in
proportion to its contribution to the difference ∆t.
In order to compute the contribution score C∆x∆t,
DeepLIFT defines the multiplier m∆x∆t as
m∆x∆t =
C∆x∆t
∆x
, (2)
and a Chain Rule to propagate the multiplier values from
output neurons to the input neurons:
m∆xi∆t =
L∑
j=1
m∆xi∆yjm∆yj∆t, (3)
UK Biobank Resource under Application Number 20168.
where yj is a neuron that is immediately downstream to
the neuron xi and L is the number of neurons in the layer
immediately downstream to xi.
We use the implementation of DeepLIFT found in Pytorch-
Captum (Paszke et al., 2019), which references Ancona et al.
(2018) for assigning an attribution score Ai to each input
feature i from the contribution scores of each input neuron
C∆x∆t, using the RESCALE rule (Shrikumar et al., 2017).
Step 3: Identify impactful SNPs With DeepLIFT, posi-
tive and negative attribution scores indicate that a feature
contributed to bringing the value of the target up or down
respectively, relative to the reference target. The magnitude
of the attribution score reflects how strongly a model relied
on that feature for a particular prediction. The most im-
pactful SNPs will consistently have the highest magnitudes.
Therefore, we take the mean of the absolute value of the
attribution scores for each input feature.
Robustness and reproducibility Given that genetic
datasets contain complex correlations between causal and
non-causal SNPs, it is important to verify the reproducibil-
ity and robustness of the attribution scores by repeating the
training and model interpretation on multiple seeds. This is
addressed in our experiments (Sec. 4).
3. Data
We conduct experiments (Sec. 4) on the following datasets.
3.1. Simulated
We follow the procedure in Hao et al. (2016) to simulate
10, 000 SNPs, 10, 000 samples, and their corresponding bi-
nary traits. In short, the M ×N genotype matrix is sampled
from a Binomial distribution: xmn ∼ Binomial(2, pimn)
with pi = ΓS, where Γ is a M × 3 matrix and Γmk ∼
Uniform(0, 0.5) for k = 1, 2 and Γm3 = 0.5. The 3 × N
matrix S has Skn ∼ Beta(a, a) for k = 1, 2 and S3n = 1.
The first 2 rows of S correspond to the position of each sam-
ple on a unit square. Smaller values of the B parameter a
clusters the population into the four corners of a unit square.
The traits are sampled from Bernoulli distributions with
parameters that are a function of a random effect vector, the
SNPs, and the spatial position of each sample:
yn ∼ B
(
σ(
M∑
m=1
βmxmn + λn + n)
)
n ∼ N (0, σ2n)
βm ∼
{
N (0, 1), if m ≤ 10
0, if m > 10.
As per Hao et al. (2016) and Tran & Blei (2018), we simulate
λn and σn as follows:
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1. Assign each sample j to a partition obtained by run-
ning K-mean clustering on the columns of the sample
frequency matrix S, with K = 3. Let the partitions be
denoted by S1, S2, and S3
2. λj = k for all j ∈ Sk
3. Draw τ21 , τ
2
2 , τ
2
3 ∼ InverseGamma(3, 1) and set
σ2j = τ
2
k , ∀j ∈ Sk.
We produce 20 different simulated datasets using four dif-
ferent values of a ∈ {0.01, 0.1, 0.5, 1} over five seeds.
3.2. UK Biobank
The UK Biobank is a population cohort including more than
500,000 genotyped participants (Sudlow et al., 2015). Us-
ing the following pre-processing, we build two datasets for
the phenotypes diabetes and glycated hemoglobin measure-
ments (HbA1c).
Filtering individuals We consider the imputed geno-
types, where we filter out individuals with more than 2%
missing genotypes, in addition to individuals with sexual
chromosome aneuploidies or with genetically inferred sex
different from the self-reported sex. We then select a subset
of the cohort of European ancestry to avoid population strat-
ification (i.e. confounding bias due to ethnicity) by using
the UK Biobank provided principal components and keep-
ing individuals near the cluster of individuals self-reporting
as of white British ancestry. To avoid including related
individuals, we randomly select one individual from pairs
with a kinship coefficient above 0.0884 (corresponding to
a 2nd degree relationship). This results in the selection of
N = 413, 173 individuals (samples).
Filtering variants After selecting the individuals to in-
clude, we filter genetic variants to be used as features. Start-
ing from all variants on chromosome 10, we filter out vari-
ants with minor allele frequency under 1%, variants with
a call rate under 99% and set genotypes with a probabil-
ity under 90% to missing. This results in the selection of
M = 336, 814 variants (SNPs) per individual.
Phenotype extraction The Diabetes phenotype is defined
based on a combination of hospitalization codes and the
self-reported verbal interview data. Specifically, we code
as cases any participant with data coding for Diabetes (field
#20002, coded as 1220) as cases, or with the ‘249’ or ‘250’
ICD9 codes, or E10, E11, E12, E13, or E14 ICD10 codes
as the primary or secondary reason for hospitalization. The
remaining individuals are used as controls. This results in a
dataset with 24,717 diabetes cases and 388,456 controls.
The HbA1c phenotype (field #30750) is extracted for
395,042 participants. If multiple measurements are avail-
able for an individual, the arithmetic mean is used. The
values are also log-transformed to ensure an approximately
normal distribution as typical in continuous trait GWAS.
Popl. sparsity a arch L1 coeff. Recall
0.01 64 by 256 1 64%
0.10 128 by 256 1 66%
0.50 128 by 256 1 70%
1.00 64 by 256 1 66%
Table 1. Models with the highest mean validation likelihood, av-
eraged over 5 seeds, for each simulation setting a. We are able to
capture at least 64% of the causal SNPs in all settings.
4. Experiments and Results
We now highlight the potential of the proposed methods.
4.1. Predicting a discrete simulated trait
We first conduct a simulation study (Sec. 3.1) to validate that
deep network feature attribution techniques can be used to
identify causal SNPs. We randomly generate 20 datasets of
10,000 individuals with 10,000 SNPs, including 10 causal
SNPs (a ∈ {0.01, 0.1, 0.5, 1} for five seeds). We train
several two-layer (first in {64, 128}, second in {128, 256})
feedforward models to predict a simulated binary trait. We
train each model on 50% of the samples, early stop on 25%
of the samples, and validate the model architectures using
the remaining 25%. We force the models to pick a handful
of SNPs by adding an L1-penalty (λ ∈ {0.01, 0.1, 1, 10}) to
the first layer weights. We then use DeepLIFT to compute
a summary score for each input SNP. We set the reference
input to be the mean genotype of all samples.
Model selection We pick the model with the best log like-
lihood on the validation set averaged over five seeds, per
spatial configuration. We verify the robustness of the perfor-
mance of the selected model by re-training and re-running
DeepLIFT on the same dataset with five more seeds. Thus
for each of the four selected model architectures, we per-
form 25 trainings, on five different datasets with the same
value of a, five times each. We consider the SNPs with the
10 highest DeepLIFT scores (in magnitude) as causal.
Results Table 1 reports the architectures of the best per-
forming models for each configuration, and the correspond-
ing average Recall (number of true positives divided by
total number of positives) over the 25 different runs. Fig-
ure 1 shows two interpretability plots of a model trained and
interpreted using two different seeds on the same dataset
(a = 0.1). Both models have comparable negative log like-
lihood on the validation set (0.25 vs 0.31) but the number
of identified causal SNPs is different. This shows how the
same model can come to rely on different subsets of fea-
tures on a dataset consisting of highly correlated features
(as is typical in genetic datasets). This necessitates train-
ing and interpreting a model on multiple seeds to verify
interpretability results.
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Figure 1. Mean absolute DeepLIFT scores with the same architec-
ture on two different seeds
4.2. Predicting Diabetes and HbA1c
In order to test the scalability and robustness of our approach
on real data, we perform experiments on genetic data ob-
tained from the UK Biobank (Sec. 3.2). We train several
two-layer (first in {32, 64, 128}, second in {64, 128, 256})
feedforward models to predict diabetes and hba1c, while
again applying the L1-penalty (λ ∈ {0.01, 0.1, 1, 10}).
We evaluate the proposed approach by comparing with
GWAS analyses adjusted for age (field #21022), sex (field
#31), and the first 10 ethnicity principal components as
provided by the UK Biobank.
Model selection We pick the model with the highest log
likelihood on the validation set. We then re-train this model
and conduct feature attribution using five random seeds.
Results Fig. 2 shows their corresponding Miami plots.
We observe that for both traits, the topmost peaks in both
halves of their respective Miami plots occur at the same
index. There is also some overlap between the secondary
peaks for Diabetes, as indicated by the second and third
vertical lines from the right. For HbA1c, the two tallest
peaks are well captured by both GWAS and DeepLIFT.
5. Conclusion
We showed that deep neural networks trained on large ge-
netic data can be interpreted to uncover interactions that
a normal GWAS would not identify. This provides a way
forward for deep models to be used for discovery of novel
interactions in genomics. We are also excited at the prospect
of capturing novel variants while predicting two or more
traits together using multi-task learning. Although the fea-
ture attribution techniques in deep networks are not as rig-
orously grounded as statistical testing of models, we hope
Figure 2. Miami plot of a linear GWAS against mean absolute
DeepLIFT scores on Diabetes (top) and HbA1C (bottom). The
best performing Diabates model had 64 by 256 hidden units, and
the best HbA1C model had 128 by 256 units. The L1 regularization
parameter was 1 for both models.
that we were able to show that they can provide useful and
reproducible results for exploratory analysis on real-world,
large biological datasets. In this work, we did not attempt
to control for confounding in the deep learning model, or
tackle the imbalance between cases and controls in the dia-
betes dataset. As future work, we will mitigate the former by
including age, sex, and principal components provided by
the UKBB, and the latter by oversampling the cases during
training. This should help reduce the number of potentially
spurious associations that will need to be validated.
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